White matter hyperintensities effect on cognition in type 2 diabetes is moderated by education level

Poster No:

267 

Submission Type:

Abstract Submission 

Authors:

Mohamed Salah Khlif1, Carolina Restrepo2, Sheila Patel3, Leonid Churilov4, Louise Burrell3, Amy Brodtmann1

Institutions:

1Cognitive Health Initiative, Central Clinical School, Monash University, Melbourne, VIC, 2Cabrini Health, Melbourne, VIC, 3Department of Medicine, University of Melbourne, Austin Health, Heidelberg, VIC, 4Melbourne Medical School, University of Melbourne, Melbourne, VIC

First Author:

Mohamed Salah Khlif  
Cognitive Health Initiative, Central Clinical School, Monash University
Melbourne, VIC

Co-Author(s):

Carolina Restrepo  
Cabrini Health
Melbourne, VIC
Sheila Patel  
Department of Medicine, University of Melbourne, Austin Health
Heidelberg, VIC
Leonid Churilov  
Melbourne Medical School, University of Melbourne
Melbourne, VIC
Louise Burrell  
Department of Medicine, University of Melbourne, Austin Health
Heidelberg, VIC
Amy Brodtmann, MBBS FRACP PhD  
Cognitive Health Initiative, Central Clinical School, Monash University
Melbourne, VIC

Introduction:

White matter hyperintensities (WMH) are a cerebral small vessel disease (cSVD) marker (Li et al., 2022). Factors that lead to WMH accumulation and to cSVD include increasing age, obesity, hypertension, and type 2 diabetes mellitus (T2DM). WMH burden has been linked to neurodegeneration and cognitive decline (Rizvi et al., 2018). Conversely, there is a positive association between education attainment level and cognitive ability across an adult life span (Lövdén et al., 2020). We conducted a moderation analysis in a group of people with T2DM to determine if education level attenuates the causal relationship between WMH volume and cognitive performance (see Fig. 1).

Methods:

Baseline multimodal MRI was completed as part of the Diabetes and Dementia (D2) (Patel et al., 2017), an observational longitudinal case control study that followed 150 adults with T2DM. Age, obesity (BMI > 30 kg/m2), hypertension (24-hour blood pressure mean > 140/90 mmHg), and education level (0/1 based on a threshold of 12 years of education, YOE) were included as covariates. WMH volumes (predictor, mm3) were estimated using manual delineations on FLAIR images and cognitive screening (response) was done using the Montreal Cognitive Assessment (MoCA) test (Nasreddine et al., 2005). The causal effects of WMH on cognitive ability were estimated and stratified by the level of education attainment. The "WeightIt" R package was used for generating the balancing weights based on the "optweight" method (https://cran.r-project.org/web/packages/WeightIt/index.html). We used the g-computation algorithm and set 'vcov' to 'HC3' for robust estimations of causal effects and confidence intervals.

Results:

We included 129 participants (age: 65.1 ± 7.2 years, men: 72): 93 participants had YOE > 12 years; 45 had current/untreated hypertension based on ambulatory BP testing, and 68 were classified as obese. The distributions of unadjusted covariates at baseline stratified by education level are shown in Fig. 1. Covariate balancing after weighting is provided in Fig. 2/A showing WMH-covariate correlations below 5%. We found a causal effect of WMH accumulation on cognitive ability (p = 0.00154, Fig. 2/C) only in the group of T2DM patients with lower level of education. This was also reflected in the plot of the average dose-response function (ADRF) in Fig. 2/B. Testing also showed that the education moderation effect was significant (p = 0.00585, Fig. 2/C).

Conclusions:

In this sample of participants with T2DM, we report a significant effect of higher education attainment in attenuating the causal effects of cSVD, reflected by WMH accumulation, on cognitive abilities. These results are consistent with the concept of cognitive resilience imparted by prior educational attainment, even in the setting of increasingly cSVD.

Disorders of the Nervous System:

Neurodegenerative/ Late Life (eg. Parkinson’s, Alzheimer’s) 1

Modeling and Analysis Methods:

Other Methods 2

Keywords:

Cerebrovascular Disease
Cognition
Degenerative Disease
STRUCTURAL MRI
Other - WMH, Hypertension, Causal inference, moderation

1|2Indicates the priority used for review
Supporting Image: fig1_abstract2.png
Supporting Image: fig2_abstract2.png
 

Provide references using author date format

Li, Y., Kalpouzos, G., Laukka, E. J., Dekhtyar, S., Bäckman, L., Fratiglioni, L., & Qiu, C. (2022). Progression of neuroimaging markers of cerebral small vessel disease in older adults: A 6-year follow-up study. Neurobiology of Aging, 112, 204-211. https://doi.org/https://doi.org/10.1016/j.neurobiolaging.2022.01.006
Lövdén, M., Fratiglioni, L., Glymour, M. M., Lindenberger, U., & Tucker-Drob, E. M. (2020). Education and Cognitive Functioning Across the Life Span. Psychol Sci Public Interest, 21(1), 6-41. https://doi.org/10.1177/1529100620920576
Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005). The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc, 53(4), 695-699. https://doi.org/10.1111/j.1532-5415.2005.53221.x
Patel, S. K., Restrepo, C., Werden, E., Churilov, L., Ekinci, E. I., Srivastava, P. M., Ramchand, J., Wai, B., Chambers, B., O'Callaghan, C. J., Darby, D., Hachinski, V., Cumming, T., Donnan, G., Burrell, L. M., & Brodtmann, A. (2017). Does left ventricular hypertrophy affect cognition and brain structural integrity in type 2 diabetes? Study design and rationale of the Diabetes and Dementia (D2) study. BMC Endocr Disord, 17(1), 24. https://doi.org/10.1186/s12902-017-0173-7
Rizvi, B., Narkhede, A., Last, B. S., Budge, M., Tosto, G., Manly, J. J., Schupf, N., Mayeux, R., & Brickman, A. M. (2018). The effect of white matter hyperintensities on cognition is mediated by cortical atrophy. Neurobiol Aging, 64, 25-32. https://doi.org/10.1016/j.neurobiolaging.2017.12.006